BioStrategic Consulting Ltd provides a range of management-level clinical development consulting services to the pharmaceutical, biotechnology and medical device industries, including: • Clinical development strategy and management, especially for development-stage companies • Conceptualization, implementation, and management of Phase 1, Phase 2, first-in-man, and proof-of principle clinical trials • IND planning and preparation • FDA and other regulatory authority submissions, meetings, and related interactions • Clinical strategic planning for small molecules, biotechnology products, immunotherapeutic agents, novel drug delivery technologies, and medical devices in virtually all therapeutic areas • New technology assessment, due diligence, and program planning • Clinical development advisory services to senior-level management (CEO, COO, CSO, BOD).